本院覽號:28A-970530
創作人:Alice Yu, You-Chin Lin, Ruey-Jen Lin
智財權:US Provisional
摘要:
Neuroblastoma (NB) is a common childhood tumor derived from primitive sympathetic neuroblasts and accounts for 15% of pediatric cancer deaths. Although current risk stratification is useful for selection of appropriate therapeutic regimens, there is still a lack of useful markers for predicting treatment failure in lower risk patients and high risk patients.
The invention relates to progmostic markers specific for neuroblastoma that can predict tumor behavior and refine risk assessment in a patient diagnosed with neuroblastoma, and more particularly to methods for delineating neuroblastoma patients into clinical risk groups by observing MicroRNA signature and expression of Dicer and Drosha.
智財技轉處聯絡人:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you